
Opinion|Videos|October 2, 2024
Bridging the Gap: Key Considerations for Physicians Interpreting Gallium-Based PET Imaging
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Key opinion leaders offer insights on closing knowledge gaps and highlight crucial factors for physicians to consider when interpreting gallium-based PET imaging results in clinical practice.
Advertisement
Video content above is prompted by the following:
- What key aspects of gallium-based PET imaging should physicians interpreting other modalities understand, and what advice do you have to address any unfamiliar nuances or challenges they may encounter?
Advertisement
Related to this article

In the latest episode of her Breast Imaging in Focus series, Manisha Bahl, MD, MPH, FSBI, discussed new research demonstrating that cancer detection rate, sensitivity and positive predictive value (PPV) for digital breast tomosynthesis (DBT) all improved with age.

Uptunity | Aneurysm reportedly identifies suspected saccular brain aneurysms larger than 3 mm on head CTA and provides quantitative comparison between exams to assess changes in known aneurysms over time.

Through enhanced insights into atherosclerotic disease, complex coronary lesions and coronary stents, photon-counting CT provides an anatomical roadmap that may improve outcomes for interventional procedures.

The PSMA PET radiopharmaceutical 64Cu-SAR-bisPSMA, which previously garnered two FDA fast track designations, more than doubled the detection of PCa lesions in comparison to 68Ga-PSMA-11 in the phase II Co-PSMA trial.

The mobile X-Ray unit DR 100s Pro reportedly offers an array of attributes to facilitate workflow efficiencies and quality imaging.

In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging’s Weekly Scan: November 8 — November 14
2
FDA Issues Breakthrough Therapy Designation for Emerging PSMA PET Agent in Men with Suspected PCa Recurrence
3
Will PCCT Lead the Next Revolution in Interventional Cardiology?
4
Agfa Radiology to Introduce AI-Powered DR 100s Pro X-Ray Platform at RSNA
5


